WallStreetZenWallStreetZen

NASDAQ: TLX
Telix Pharmaceuticals Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Telix Pharmaceuticals earnings were $31.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TLX earnings report on Dec 31, 2024 announced Q4 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TLX reported annual earnings of $31.0M, with 774.7% growth.

TLX earnings history

Current Revenue
$486.5M
Current Earnings
$31.0M
Current Profit Margin
6.4%

TLX Return on Equity

Current Company
13.9%
Current Industry
-2%
Current Market
34.1%
TLX's Return on Equity (13.9%)... subscribe to Premium to read more.
High Return on Equity Performance

TLX undefined

Current Company
5.2%
Current Industry
-0.4%
TLX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TLX announces earnings.

TLX undefined

Current Company
7.84%
Current Industry
5.9%

TLX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TLX$58.49M$31.40MN/AN/A
BPMC-$11.50M-$67.09MN/A-$1.07
SRPT$314.67M$235.24MN/A$2.47
VRNA-$138.53M-$173.42MN/A-$2.16
TGTX$49.69M$23.38M+77.78%$0.16
View Top Biotech Stocks

Telix Pharmaceuticals Earnings Reports & History FAQ

What were Telix Pharmaceuticals's earnings last quarter?

Telix Pharmaceuticals (NASDAQ: TLX) reported Q4 2024 earnings per share (EPS) of N/A, up N/A year over year. Total TLX earnings for the quarter were N/A. In the same quarter last year, Telix Pharmaceuticals's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Telix Pharmaceuticals stock.

Is Telix Pharmaceuticals profitable or losing money?

As of the last Telix Pharmaceuticals earnings report, Telix Pharmaceuticals is currently profitable. Telix Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $31.01 million, a 774.65% increase year over year.

What was TLX's earnings growth in the past year?

As of Telix Pharmaceuticals's earnings date in Q2 2025, Telix Pharmaceuticals's earnings has grown year over year. TLX earnings in the past year totalled $31.40 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.